thetaOwl
HomeOptionsMSFTReports

MSFT

Microsoft CorporationClose $393.83EOD only
Max Pain
$400.00
Next expiry Jun 17, 2026
Expected Move
±$5.86
1.5% from close
Price Gap
+6.17
Distance to max pain
IV Rank
91
High premium
P/C OI
0.43
Slightly call-heavy
Consensus
6.0/10
Bullish tilt
Published snapshot: Jun 16, 2026 close
End-of-day snapshot

This page reflects MSFT options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Jun 16, 2026 close
MSFT Directional Report
Analysis based on market close June 17, 2026
DirectionalTheta GangFlowEarningsConsensus

Historical consensus-supported lens with full content, report chain context, and metric rail.

Outlook

Bearish bias short-term due to spot below max pain, negative GEX, and below MP pressure. DEX long provides support, limiting downside; range-bound drift with bearish tilt.

Confidence:
7 / 10
Base 5; +2 GEX/flow aligned; -0.5 spot 4.1% below MP; +0.5 VIX 18; net 7.0.
Supports: GEX/flow alignment, VIX 18, spot below MP.
Conflicts: Flow mixed, DEX long cushions downside, spot far from MP.
📉Below MP: spot 4.1% below max pain, bearish pin risk.
⚖️GEX/flow aligned: dealer positioning supports directional move.
📊DEX long: $96M shares long delta caps downside.

Regime Classification

Vol Regime
Normal
IV is normal relative to typical range, not elevated despite market dip.
Gamma Regime
Trending
GEX -$41.5M, dealers net short gamma; trending gamma builds short gamma pressure.
Flow Regime
Mixed
Flow is mixed, no clear premium direction; put/call activity balanced.
Spot vs Max Pain
Below
Spot trades below max pain ($395-$400), suggesting bearish pinning risk but room to drift lower.
Thesis duration: Event-specific — Focus on June 17 weekly expiry with dealer positioning and below MP pressure.

Price Range Forecast

Next 2 days
$372.17$385.65
Below MP and negative GEX, drift lower likely.
Next 1 week
$368.99$388.84
Support at 370 if held; resistance at 388.
Next 2 weeks
$370.21$387.61
Range-bound, no catalyst; watch for breakout above 388 or below 370.

Key Levels

Max pain pins: $395 (2026-06-17); $400 (2026-06-18); $392 (2026-06-22)
EM guardrails: 2d $372.17/$385.65; 1w $368.99/$388.84
Support: $370.21
Resistance: $387.61 · $395.00
Structural: Support: 370.21; Resistance: 387.61, 395.00; 2d guardrails 372.17/385.65; 1w guardrails 368.99/388.84

Dealer Positioning (GEX/DEX)

GEX: $-41.5M

DEX: +96.2M shares

Gamma flip: N/A

NTM gamma: GEX -$41.5M (negative gamma), DEX +96.2M shares (long delta). Negative gamma amplifies moves; long delta cushions but risks hedging on downside.

IV Analysis

IV vs VIX: IV normal, likely near VIX 18.44 level; not rich or cheap.

Term structure: Flat for weekly expiry; no event kinks.

Skew: Skew relatively flat; no actionable vol structure.

Flow Analysis

Net premium: Net put premium $1.35B, P/C vol ratio 0.93 suggests bearish bias.

Directional prints: 32.5 put 385 ITM 2026-06-17 — Vol/OI 16.2, aggressive put buying (31.7k vs 1.9k OI), bearish view. 22.9 put 382.5 ITM 2026-06-17 — Vol/OI 20.3, large put accumulation, reinforces bearish sentiment.

Unusual: 8.4 call 382.5 OTM 2026-06-17 — Vol/OI 111, extreme volume in deep OTM calls (0.01), likely speculative buys at near-zero cost. 13.3 call 385 OTM 2026-06-17 — Vol/OI 107, similar pattern, concentrated OTM call buying. 87.1 put 422.5 ITM 2026-06-18 — High IV 87%, deep ITM put with 14.7 vol/OI, likely hedging or bearish bet.

Risks & Catalysts

!Upside risk from strong DEX buying support.
!IV expansion if market selloff continues.
!Gamma squeeze if spot rallies to max pain.

Strategy Viability

StrategyEdgeBest SetupPrimary Risk
Bear put spreadModerate-Strong
Buy 2026-08-21 $355.00/$330.00 put spread
Why now: Spot below max pain, negative GEX, aggressive put flows; DEX limits downside, debit spread suits.
Upside from DEX support or gamma squeeze if spot rallies.
Call credit spreadModerate
Sell 2026-08-21 $420.00/$465.00 call spread
Why now: Elevated IV and bearish bias; sell call credit to profit from stagnation/downside.
Upside risk if spot rallies through short call; gamma squeeze.

Top Plays

#1
Bear Put Spread
Buy 2026-08-21 $355.00/$330.00 put spread
Debit spread to profit from decline using elevated put IV.
Why this play: Direct bearish play; spot below max pain, negative GEX, aggressive put flow. DEX limits downside, debit spread defines risk.
Debit: $5.69-$6.96
Max loss: $6.96
BE: $348.04
Mgmt: Exit above invalidation level (387.61). Take profit or hold to expiry.
Bearish traders with defined risk tolerance.
#2
Call Credit Spread
Sell 2026-08-21 $420.00/$465.00 call spread
Sell OTM call spread to collect premium.
Why this play: Alternative bearish play; profits from stagnation/downside with time decay and IV contraction.
Credit: $5.63-$6.88
Max loss: $38.12
BE: $426.88
Mgmt: Monitor invalidation level; close if IV expands sharply.
Income-seeking bearish traders.

Watchlist Triggers

Entry Triggers
IFIF MSFT trades below 372.17 (2d lower guardrail) and bias remains bearish → THEN buy the 2026-08-21 $355/$330 put spread (msft_bear_put_1)
IFIF MSFT stays below 385.65 (2d upper guardrail) and bearish bias holds → THEN sell the 2026-08-21 $420/$465 call spread (msft_call_credit_1)
Exit Triggers
EXITIF MSFT rises above 387.61 (invalidation level) → THEN close both bear put spread and call credit spread

Tactical Summary

MSFT bearish short-term; spot below max pain with negative GEX. DEX provides support, limiting downside. Key range: 370-388. Favor bear put spread or call credit spread. Monitor invalidation at 387.61.
How to Use These Reports
This directional reflects the market close on June 17, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.